Regen BioPharma Inc (RGBP)

[Carter]

"...it will take good results from sales" - you mean after the drugs go through clinical trials successfully, then FDA approval, then sales, THEN the pps rises?

My friend, you'd miss out on virtually every screamer of a biotech stock in the history of biotechs if you waited until sales revenues.

You know how much Kite Pharma had in sales revs before getting acquired? $0.00

All their stuff was preclinical, except one that was in early P1.

Know what Kite was acquired for? $12 billion.

Regen doesn't need anything even close to Kite's valuation to warrent massive pps increases from the .02 levels.